Gilead Sciences Launches Age Positively Initiative to Address Unique Challenges of Aging Population Living with HIV
Gilead Sciences, Inc. (NASDAQ: GILD) today announced it is providing $17.6 million in grants to 30 organizations in the United States through the Gilead HIV Age Positively initiative. This effort aims to enhance the lives of individuals aging with HIV by focusing in three priority areas: improving care coordination, increasing resources for better well-being, and educating and informing policies that impact people living and aging with HIV. Estimates suggest that by 2030, more than 80 percent of people living with HIV will face at least one age-related medical condition, compared to just 29 percent in 2010.
“Community partners who work tirelessly to improve the lives of people living with HIV inspire us all,” said Amy Flood, Senior Vice President of Public Affairs at Gilead. “Gilead understands science alone is not enough to help people lead longer, healthier lives. That’s why we work together with advocates, healthcare providers and community organizations to identify the unique challenges people aging with HIV experience and dedicate resources to maximize impact in communities across the country.”
The HIV Age Positively grantees include longtime advocacy organizations, who are now better equipped to provide life-saving services to their communities, as well as newer organizations that add to the overall effort to strengthen care and services for this growing population. Each grantee was selected for their unique ability to articulate interventions that have the potential to transform the quality of life for people aging with HIV.
“Anyone who lived through the 1980s and ‘90s remembers the generation of Americans we lost to the HIV epidemic and the heroic work this community has done together to increase the life expectancy of people living with HIV," said Kelsey Louie, Chief Executive Officer, Gay Men’s Health Crisis. "As they have in the past, Gilead brought experts together, listened to what our community needed and identified the organizations best equipped to tackle specific problems. Funding from HIV Age Positively is going to help long-term survivors combat loneliness, obtain access to the resources and support they need and create better, more personalized healthcare. Everyone deserves to live a long and healthy life and this program is going to help make that possible for countless people living and aging with HIV."
Aging people living with HIV face a unique set of challenges, and healthcare providers and the broader community of allies need additional resources to meet their needs. As part of the HIV Age Positively effort, Gilead convened an advisory board of experts with deep insights into the subject of aging with HIV.
“The advisory board created a space for leaders to come together and address these unmet needs of people aging with HIV,” said Stephen Karpiak, Ph.D., Senior Director of Research at ACRIA Center on HIV and Aging at GMHC, and a member of the advisory board. “By spotlighting and uplifting potential interventions, we aim to shine a bright new light on the too often forgotten and marginalized community of people aging with HIV: the challenges they face, the resources they need and the support they deserve.”
The advisory board members included healthcare providers, researchers and community advocates from AIDS Project Los Angeles (APLA), Test Positive Awareness Network (TPAN), the University of Pittsburgh, Boston University, ACRIA, University of California, San Diego, HTW Campaign, SAGE and the HIV Vaccine Trials Network.
This group determined that addressing the interrelated challenges within our healthcare system and the general HIV community, like stigma, loneliness and better coordination of care, is essential in reaching a viable solution to these challenges.
Recipient grantees include:
- Abounding Prosperity – Dallas, TX
- The AIDS Institute, Inc. – Nationwide
- AIDS Project – New Haven, CT
- American Indian Community House, Inc. – Nationwide
- APLA Health & Wellness – California Statewide
- The Association of Nurses in AIDS Care – Nationwide
- Borrego Community Health Foundation – Southern California
- Cascade AIDS Project – Oregon and Southwest Washington
- Center for Health Justice, Inc. – Los Angeles, CA
- Community Healthcare Network, Inc. – New York, NY
- Family Health Centers of San Diego, Inc. – San Diego, CA
- Gay Men’s Health Crisis – Nationwide
- HealthHIV – Nationwide
- Hektoen Institute for Medical Research – Chicago, IL
- Legal Aid Service of Broward County, Inc. – Broward County, FL
- Montefiore Medical Center – New York, NY
- My Brother’s Keeper – Mississippi (Statewide)
- New Orleans Advocates for GLBT Elders (NOAGE) – New Orleans, LA
- Professional Association of Social Workers in HIV & AIDS – Nationwide
- Project Open Hand – San Francisco, CA
- Regents of the University of California at San Diego – San Diego, CA
- SAGE – Nationwide
- San Francisco AIDS Foundation – San Francisco, CA
- Shanti Project, Inc. – San Francisco, CA
- Thrive SS, Inc. – Nationwide
- Test Positive Awareness Network, Inc.– Chicago, IL
- University of California, San Francisco – San Francisco, CA
- University of Maryland Baltimore Foundation Inc. – Baltimore, MD
- Us Helping Us - People Into Living, Inc. – Washington, DC
- Washington Hospital Center Corporation – Washington, DC
For more information visit: https://www.gilead.com/purpose/partnerships-and-community/hiv-age-positively
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Concierge Auctions and Engel & Völkers to Sell $29.9 Million New Jersey Estate Without Reserve20.5.2019 17:32:00 CEST | Pressemelding
A 32,507-square-foot Saddle River residence will sell at auction next month via leading global firm Concierge Auctions. Known as “Stone Palace on the Hill,” the home features a glass elevator, tennis court, racquetball court, wine cellar, and two swimming pools. 144 East Saddle River Road was previously listed for $29.9 million and will sell Without Reserve in cooperation with Alina Pogorelova and Lisa Troyano-Ascolese of Engel & Völkers. Bidding, which will be held via Concierge Auctions’ online marketplace, will open on June 21st and close on June 27. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005686/en/ 144 East Saddle River Road | New York Metro, NJ (Photo: Business Wire) “The quality of work and detail that went into building this home is perhaps the most impressive element of the property,” said Troyano-Ascolese. “With astounding details from custom gold-plated and forged-iron railings to a complete hand-cut
CNIM to Optimize Renewable Heat Production for Nantes District Heating20.5.2019 17:20:00 CEST | Pressemelding
CNIM, a French international industrial equipment manufacturer and integrator, has entered into an agreement concerning the energy efficiency optimisation at the waste-to-energy plant serving the cities of Nantes and Saint Nazaire, in the North West of France. Under the terms of this agreement, CNIM will install an absorption heat pump to boost the supply of hot water to Nantes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005678/en/ Heat-Pump_13MW_Brive (c) CNIM The delivery is scheduled for October 2019. The new system has been designed to inject 3.1 MW of heat energy into Nantes' district heating system. 2018: Two contracts to upgrade heat networks in France and Switzerland Prior to this agreement, CNIM won two other major contracts to upgrade the energy efficiency of waste-to-energy plants in France and Switzerland, and to supply district heating networks with renewable energy. Supplying 30 MW to Basel's district
MyHeritage utvides til Helse; Lanserer ny DNA-test som tilbyr omfattende og personlig helseinnsikt for forbrukere20.5.2019 17:15:00 CEST | Pressemelding
MyHeritage, den ledende globale tjenesten for familiehistorie og DNA-testing, kunngjorde i dag en stor utvidelse av DNA-produktlinjen med lanseringen av MyHeritage DNA Helse+Aner-testen. Testen gir en ny dimensjon av genetisk innsikt med omfattende helserapporter som kan styrke fremtidige helse- og livsstilsvalg. Det er en utvidelse av den nåværende MyHeritage DNA-testen, og inkluderer sine søylefunksjoner: en prosentvis nedbryting av etnisk opprinnelse og samsvar med slektninger gjennom delt DNA. MyHeritage er nå det eneste globale DNA-selskapet for forbrukere som tilbyr et omfattende helse- og aneprodukt på over 40 språk. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20190520005670/no/ MyHeritage utvides til Helse; Lanserer ny DNA-test som tilbyr omfattende og personlig helseinnsikt for forbrukere (Graphic: Business Wire) Lanseringen av Helse+Aner-produktet skiller MyHeritage som den eneste hovedtjenesten som forbinde
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD120.5.2019 16:46:00 CEST | Pressemelding
Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVCa) in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD). Results show that nintedanib slows the loss of pulmonary function in patients with SSc-ILD compared to placebo. Patients taking nintedanib showed a 44% reduction in the rate of decline of their lung function, measured in FVC assessed over 52 weeks1. These new data were today published in the New England Journal of Medicine (NEJM) and presented to the medical community at the American Thoracic Society (ATS) International Conference, in Dallas, USA. SENSCIS® is the largest randomised controlled trial to be conducted in patients with SSc-ILD, a disease for which there are currently no approved treatments.1,3,4 Results also showed that nintedanib had a safety and tolerability profile similar to that observed in patients with idiopathic pulmonary fibro
Airship Bolsters its Senior Leadership Team for Accelerated Global Growth20.5.2019 13:00:00 CEST | Pressemelding
Customer engagement company Airship today announced four senior leadership appointments including Dale Flores as vice president of sales Americas, Neil Gariepy as vice president of infrastructure and security, David King Harris as vice president of sales EMEA, and Jeff Winsor as vice president of technology services. Dale Flores will lead the rapid expansion of Airship’s Americas sales organization, growing solution adoption to generate greater business value for customers throughout the region. Flores brings two decades of global SaaS sales and customer success management experience to Airship, including over 14 years leading sales teams at Silverpop and IBM. Most recently, Flores was head of customer success at digital customer experience company Clicktale. Neil Gariepy will lead Airship’s customer engineering, infrastructure and security teams, with responsibility for expanding Airship’s infrastructure globally while further optimizing its cost, performance and security. Gariepy bri
Analogix Introduces Its VirtualLink™ Reference Design for High-Performance Gaming Notebooks20.5.2019 13:00:00 CEST | Pressemelding
Analogix Semiconductor, Inc. today announced the availability of its VirtualLink™ Reference Design which enables VirtualLink directly on the motherboard of high-performance gaming notebooks, allowing them to support virtual reality (VR) over the USB-C™ connector. External accessories can also leverage the reference design to interface legacy graphics processing units (GPUs) to future VirtualLink-enabled VR head-mounted displays. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005132/en/ Analogix VirtualLink™ Reference Design brings VR support over the USB-C™ connector to high-performance gaming laptops. (Graphic: Business Wire) Introduced by a consortium led by NVIDIA, Oculus, Valve, AMD, and Microsoft, the VirtualLink Alternate Mode of USB Type-C™ was designed to deliver the power, display, and data required to power VR headsets through a single USB Type-C connector, eliminating the need for multiple cables. It expands